Skip to Content
COVID-19 Response and Update
International
  • About
        • AboutWe challenge convention so healthy can be possible for all
        • Our Story
          • Amneal at-a-glance
          • Our Founders
        • Our Purpose & Commitments
        • Our Culture
          • Rise, Lead, Succeed
        • Our Milestones
        • Leadership
          • Executive Leadership
          • Board of Directors
        • Locations
        • Responsibility
          • The Amneal Patient Assistance Program
          • Product Donations
          • National and Local Philanthropy
          • Compliance and Ethics
        • Awards & Recognition
  • Products
        • ProductsWe produce quality generic, specialty and biosimilar medicines
        • Our Portfolio
          • Generic Products
          • Specialty Products
          • Product Catalog
        • Quality
        • Drug Safety
          • Adverse Event Reporting
          • Medical Inquiries
          • Product Complaints
        • Operations
        • Amneal Products
  • Research & Development
        • Research & DevelopmentWe invest significantly in new product development
        • Generics R&D
        • Specialty R&D
          • Drug Delivery Technologies
        • Product Partnering
        • Amneal Research and Technology
  • Investors
        • InvestorsBecome an Informed Investor
        • Financial Reports
          • SEC Filings
          • Annual Reports
          • Quarterly & Other Reports
        • Events & Presentations
        • Stock Information
        • Corporate Governance
          • Policies
          • Executive Officers & Directors
          • Board Committees
        • Investor Resources
          • Analysts
          • Investor FAQ
          • Email Alerts
          • Information Request
          • RSS Feeds
        • Amneal Investors
  • News
  • Careers
        • CareersJoin our quest to make healthy possible
        • Total Rewards
        • Search Our Career Opportunities
        • Amneal Careers
  • Contact
  • Customer Login
Amneal Pharmaceuticals

Research & Development

We invest significantly in new product development

Our R&D strategy is led by a deeply accomplished in-house development team and supplemented by creative product development partnerships with external stakeholders. The focus of our R&D strategies is ensuring the ongoing development of important and value-generating products within our Generic and Specialty Pharma divisions.

 

Learn more about our R&D capabilities:

Generic R&D
Generic R&D
Specialty R&D
Specialty R&D
Product Partnering
Product Partnering
  • Privacy Notice
  • Privacy Shield
  • Copyright & Legal Disclaimer
  • Web Accessibility
  • Linkedin
  • NABP DDA Accreditation
© 2021 Amneal Pharmaceuticals LLC.
All rights reserved.
We use cookies for statistical and measurement purposes, to help improve our website and to allow us and our partners to provide you with more relevant information. By continuing
to navigate this site, closing this box, or by clicking here you are indicating your consent to our use of cookies. To find out more, including how to withdraw your consent, click hereACCEPTREFUSE
Revoke cookies